Literature DB >> 17581013

Hydatid disease in Toposaland, Southern Sudan.

J K Magambo1, E Zeyhle, T Wachira.   

Abstract

A total of 1010 people in Toposa-land Southern Sudan were screened for hydatid disease using a portable ultrasound scanner. The prevalence of the disease was shown to be 3.5% with a majority of the cysts (60%) being located in the liver. Unlike the situation observed among the Turkana people, the level of hydatid infection within various age groups depict progressive linear increase. In addition, the level of the disease infection in both sexes show no significant difference whereas in Turkana the prevalence in women is twice that found in men. The occurrence of such differences within two culturally closely related communities is an enigma requiring further investigations. In the absence of guaranteed source of funding on a long term basis which is essential for a hydatid control programme, the control measures recommended include incorporation of hydatid education into the school and health curriculum.

Entities:  

Year:  1998        PMID: 17581013

Source DB:  PubMed          Journal:  Afr J Health Sci        ISSN: 1022-9272


  3 in total

1.  Cystic echinococcosis in Mundari tribe-members of South Sudan.

Authors:  Barclay T Stewart; Joseph Jacob; Timothy Finn; Mounir Lado; Robert Napoleon; Simon Brooker; Paul S Sidhu; Jan Kolaczinski
Journal:  Pathog Glob Health       Date:  2013-10-17       Impact factor: 2.894

2.  Secondary peritoneal hydatidosis, the challenges of echinococcal disease in South Sudan: a case report.

Authors:  Richard William Thomas; Rwth Ellis-Owen; Daniel Winson
Journal:  Pan Afr Med J       Date:  2015-01-06

3.  Identification of <i>Echinococcus granulosus</i> strains using polymerase chain reaction-restriction fragment length polymorphism amongst livestock in Moroto district, Uganda.

Authors:  Martin Chamai; Leonard Omadang; Joseph Erume; Michael Ocaido; Peter Oba; Emmanuel Othieno; Straton Bonaventure; Annah Kitibwa
Journal:  Onderstepoort J Vet Res       Date:  2016-07-29       Impact factor: 1.792

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.